Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) Net Income towards Common Stockholders (2018 - 2025)

AVITA Medical filings provide 8 years of Net Income towards Common Stockholders readings, the most recent being -$11.6 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders changed 0.39% to -$11.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.6 million, a 21.42% increase, with the full-year FY2025 number at -$48.6 million, up 21.42% from a year prior.
  • Net Income towards Common Stockholders hit -$11.6 million in Q4 2025 for AVITA Medical, up from -$13.2 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $37.6 million in Q4 2023 to a low of -$18.7 million in Q1 2024.
  • Median Net Income towards Common Stockholders over the past 5 years was -$9.7 million (2022), compared with a mean of -$7.7 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 785.6% in 2023 and later plummeted 130.77% in 2024.
  • AVITA Medical's Net Income towards Common Stockholders stood at -$5.9 million in 2021, then grew by 7.73% to -$5.5 million in 2022, then soared by 785.6% to $37.6 million in 2023, then crashed by 130.77% to -$11.6 million in 2024, then fell by 0.39% to -$11.6 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025) per Business Quant data.